[HTML][HTML] Paradoxical reactions to anti-TNFα and anti-IL-17 treatment in psoriasis patients: are skin and/or gut microbiota involved?
Z Jiraskova Zakostelska, Z Reiss… - Dermatology and …, 2023 - Springer
Psoriasis is a chronic, immune-mediated, inflammatory disease primarily affecting the skin. It
is currently coming to light that patients with psoriasis have disrupted intestinal barrier and …
is currently coming to light that patients with psoriasis have disrupted intestinal barrier and …
[HTML][HTML] Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?
ZJ Zakostelska, Z Reiss… - Dermatology and …, 2023 - ncbi.nlm.nih.gov
Psoriasis is a chronic, immune-mediated, inflammatory disease primarily affecting the skin. It
is currently coming to light that patients with psoriasis have disrupted intestinal barrier and …
is currently coming to light that patients with psoriasis have disrupted intestinal barrier and …
Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?
ZJ Zakostelska, Z Reiss… - Dermatology and …, 2023 - pubmed.ncbi.nlm.nih.gov
Psoriasis is a chronic, immune-mediated, inflammatory disease primarily affecting the skin. It
is currently coming to light that patients with psoriasis have disrupted intestinal barrier and …
is currently coming to light that patients with psoriasis have disrupted intestinal barrier and …
Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?
Z Jiraskova Zakostelska, Z Reiss… - Dermatology & …, 2023 - search.ebscohost.com
Psoriasis is a chronic, immune-mediated, inflammatory disease primarily affecting the skin. It
is currently coming to light that patients with psoriasis have disrupted intestinal barrier and …
is currently coming to light that patients with psoriasis have disrupted intestinal barrier and …
Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?
Z Reiss, H Tlaskalova-Hogenova, F Rob - Dermatology and …, 2023 - europepmc.org
Psoriasis is a chronic, immune-mediated, inflammatory disease primarily affecting the skin. It
is currently coming to light that patients with psoriasis have disrupted intestinal barrier and …
is currently coming to light that patients with psoriasis have disrupted intestinal barrier and …
[引用][C] Paradoxical Reactions to Anti-TNFa and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?
ZJ Zakostelska… - Dermatol Ther (Heidelb …, 2023 - europepmc.org
Psoriasis is a chronic, immune-mediated, inflammatory disease primarily affecting the skin. It
is currently coming to light that patients with psoriasis have disrupted intestinal barrier and …
is currently coming to light that patients with psoriasis have disrupted intestinal barrier and …